The association of Addison's disease with autoimmune disorders is a frequent finding (Nerup, 1974; Neufeld et al., 1981; Meyerson et al., 1988; Kasperlik-Załuska et al., 1991; Kong & Jeffcoate, 1994) , while secondary adrenal insufficiency accompanied by thyroid autoimmunity or other immune diseases is an unusual condition (Kojima et al., 1982; Okuno et al., 1993; Thodou et al., 1995) . The origin of the isolated ACTH deficiency is uncertain in most cases. In the patients with secondary adrenal failure co-existing with an autoimmune process a common autoimmune aetiology may be considered. In the last 30 years we have observed in the Department of Endocrinology (Centre for Postgraduate Medical Education, Warsaw, Poland) 102 patients (87 women and five men) with secondary adrenal insufficiency of unknown origin. In this report endocrine and immunological studies were carried out on a group of patients with secondary adrenal insufficiency accompanied by thyroid immunity or some other autoimmune disorders.
Patients and methods

Patients
The study included 24 patients, 23 women aged 17-72 years (mean 45·5) and one man, aged 69 years, at the time of the first admission. The main presenting features comprised weakness and fatigue, postural dizziness and orthostatic hypotension. The clinical data are shown in Table 1 . All women of reproductive age had regular menses except patient no 11, who was amenorrhoeic for 3 months prior to hydrocortisone replacement therapy. No signs of an intrasellar tumour were observed in these patients and conventional X-ray studies did not reveal pituitary fossa enlargement in any of them. The first patient in this series (1) was admitted to the Department of Endocrinology in 1971 because of long-term insulin-dependent diabetes mellitus (IDDM), vitiligo and recent signs and symptoms of hypothyroidism and adrenal failure (Kasperlik-Załuska et al., 1974) . We could not perform all the assays on this patient, because they were not available at the time of study. Thyroid function was evaluated by a 24-h 131 iodine uptake (T 24 ¼ 2·4%, normal: 28-55%). She died 9 years later following a cerebral apoplexy due to an autoimmune thrombocytopenia. IDDM was also observed in patient 10, who had a history of premature ovarian failure (POF). Pernicious anaemia with antiparietal autoantibodies was revealed in two patients (7, 21), while vitiligo was present in the male patient (20). Overt hypothyroidism was seen in 14 patients. Four women (10, 11, 16, 22) had hyperthyroidism in their previous medical history, treated with methimazole (Graves' disease in patients 11, 16, 22 and Hashi-toxicosis in patient 10). Additionally we describe a 58-year-old woman with Addison's disease, in whom hyperpigmentation disappeared after 18 years of replacement therapy, simultaneously with a fall in plasma ACTH concentration from 320 ng/l to a low normal limit. A history of pregnancy or pregnancies, 4-40 years prior to the study, was noted in 18 patients (patients 1, 5, 17, 18, 21, 22 not being pregnant before the study). A young patient (5) became pregnant 3 years after the diagnosis of secondary adrenal insufficiency had been established, and she delivered a healthy infant. 
Methods
Twenty-four-hour urinary excretion of 17-hydroxycorticosteroids (17-OHCS) by the Silber and Porter method (normal range: 6·1-19·3 mmol/24 h) was determined in basal conditions and during tetracosactrin (Synacthen Depot, Ciba) administration (0·5 mg i.m. every 12 h, for 2 days). In eight patients (1-6, 12, 13) the test with metyrapone (Metopiron, Ciba) was also performed (with a dose of 750 mg every 6 h for 2 days, urine being collected every 24 h for 17-OHCS measurements). Plasma ACTH concentration was determined by a radioimmunometric assay (Hodgkinson et al., 1984) (Cis-France).
The tests of adrenal function were performed when the patients were euthyroid. Serum thyroxine (T 4 ,), LH, FSH and PRL levels were measured by radioimmunoassay, and TSH by a radioimmunometric method (Spectria, Finland). In four patients (4, 5, 12, 17) TRH stimulation of TSH was performed. In six patients (2, 3, 5, 11, 16, 24) a test with metoclopramide (10 mg orally) was performed with PRL measurements at 0, 60 and 120 min. Normal basal values were: cortisol 209-692 nmol/l at 0900 h and 110-390 nmol/l at 2200 h; ACTH 20-60 ng/l (4·4-13·6 pmol/l) at 0900 h and 12·5-29·0 ng/l (2·2-6·4 pmol/l) at 2200 h; thyroxine (T 4 ) 54-150 nmol/l; TSH 0·35-5·0 IU/l; LH, women, 1·0-12·6 U/l, menopause 9·0-75·0 U/l, men 1·0-5·8 U/l; FSH 1·0-9·3 U/l, menopause 31-134 U/l, men 1·0-10·5 U/l; PRL 87-725 mU/l. Serum antithyroglobulin (aTg) and antimicrosomal autoantibodies were detected by a haemagglutination test (Thymune T and Thymune M, respectively, and Murex, UK) (normal values Ն1:120). Autoantibodies against thyroid peroxidase (TPO) were determined as described previously (KasperlikZałuska et al., 1994) (normal values >1:1000).
Magnetic resonance imaging (MRI) was performed in nine patients (5, 12, 14, 16, 17, 20, 21, 22, 24) , the images being acquired in sagittal and coronal planes.
Results
The results of the most important investigations are summarized in Table 1 .
Basal urinary 17-OHCS excretion in all the patients was low and showed a gradually increasing response to the daily administration of ACTH depot in cases 1-24. No distinct response to metyrapone was observed in eight patients under investigation (the 17-OHCS values ranging from 3·0 to 7·7 mmol 24 h). Low serum cortisol levels were accompanied by subnormal or low normal ACTH concentrations. In patient 25 (with Addison's disease) no response to tetracosactrin administration was revealed. The initial high plasma ACTH levels (320 ng/l) fell to low normal limit 18 years after the onset of adrenal failure, simultaneously with skin depigmentation. She was treated with hydrocortisone 30 mg and fludrocortisone, 0·1 mg daily. In the first 2 years of Addison's disease a dose of only 0·05-1 mg of fludrocortisone appeared to be sufficient. The primary hypothyroidism was revealed in the 4th year of Addison's disease and thyroxine replacement therapy was introduced. After about 6 years the hypothyroidism remitted spontaneously for about 1 year. Thereafter severe primary hypothyroidism recurred and thyroxine therapy was reintroduced. Plasma ACTH levels have remained low during further observation.
Overt hypothyroidism with low serum T 4 levels was found in 14 patients (see Table 1 ). Serum TSH concentration was increased in 12 of them, and only in two women (15, 23) was it low or normal. Subclinical hypothyroidism was diagnosed in three patients (9, 12, 20) . In three women (7, 8, 18 ) the presence of antithyroid autoantibodies was the only sign of thyroid immunity. Three patients, treated previously for thyrotoxicosis, were euthyroid at the time of investigation; in patient 10 mild hyperthyroidism was present during the study. The TSH responses following the TRH administration reached the peak values from 21 to 136 IU/l. Serum PRL levels were found to be in normal limits. The peak PRL values following stimulation with metoclopramide ranged from 870 to 5307 mU/l in patients 2, 3, 5 and 11 (reactive hyperprolactinaemia in three patients). In patient 24 the serum PRL concentrations were 87 (before) and 145 and 116 mU/l (during the test). Serum LH and FSH concentrations were within normal limits in all women in reproductive age and high in all but one of the post-menopausal patients.
In all the patients antithyroid autoantibodies were revealed. In only two patients (2, 20) were autoantibodies against thyroid peroxidase not found in significant titre; however, in case 20 the antimicrosomal autoantibodies determined 2 years earlier were 1:3240. The TPO antibodies were determined twice during the study in 15 patients, with an interval of 1-4 years. The highest TPO values are shown in Table 1 ; however, later TPO assays revealed lower titres in 13 patients while in two patients they rose. The antithyroglobulin antibodies, ranging from 1:120 to 1:9720, were detected in 14 patients. The antimicrosomal antibodies (not shown in Table 1 ) were found in 16 patients, ranging from 1:360 to 1:3240. In the remaining patients the aMic antibodies ranged from 1:80 to 1:120.
MRI examinations revealed partially empty sella in six patients (12, 14, 16, 20, 21, 22) , empty sella in patient 24, slight enlargement of the pituitary gland in patient 5 and normal pituitary size in patient 17.
Discussion
Isolated ACTH deficiency is characterized by low cortisol secretion accompanied by low or low normal plasma ACTH concentration and normal production of all other pituitary hormones. Its aetiology is uncertain in most cases.
Our own observations on patients with secondary adrenal failure associated with an autoimmune disease (KasperlikZałuska et al., 1993) and some case reports (Kojima et al., 1982; Roosens et al., 1992; Okuno et al., 1993; Thodou et al., 1995) support the suggestion of an autoimmune origin of this disease. Lymphocytic hypophysitis of autoimmune aetiology was described by several authors as the cause of isolated pituitary hormone deficiency or panhypopituitarism (Goudie & Pinkerton, 1962; Raczyńska et al., 1974; Pestell et al., 1990; Jenkins et al., 1995; Powrie et al., 1995; Thodou et al., 1995) . Sometimes the lymphocytic infiltration can cause pituitary expansion mimicking the features of a pituitary tumour, with visual deterioration due to chiasmal compression (Pestell et al., 1990) , severe headaches (Jenkins et al., 1995) , nausea and vomiting (Powrie et al., 1995) and even visual loss (Thodou et al., 1995) . No such dramatic features were observed in our patients. The largest series containing 16 patients with lymphocytic hypophysitis, was described by Thodou et al. (1995) and compared with the published literature. A review of the literature, including 38 cases and additional two new ones, has been reported recently (Powrie et al., 1995) .
Typically, the onset of lymphocytic hypophysitis is related to pregnancy, but this is not always the case. In our patients, 18 women had been pregnant in their past history; however, six other female patients had not been pregnant before the onset of the adrenal insufficiency. Additionally, there was one man in our group of patients.
Thyroid autoimmunity was the most frequent finding accompanying secondary adrenal failure in our material, as in patients with Addison's disease (Kasperlik-Załuska et al., 1994) . It was manifested by overt or subclinical hypothroidism, thyrotoxicosis and/or the presence of circulating antithyroid antibodies. In some cases a transient improvement of thyroid function in the course of Hashimoto's disease was observed. In the reviews of the previously published reports on lymphocytic hypophysitis (Pestell et al., 1990; Thodou et al., 1995) we found only a few cases with co-existence of other immune disorders, such as diabetes mellitus, vitiligo, pernicious anaemia or premature ovarian failure. Vitiligo is believed to be a very rare sign in secondary adrenal insufficiency, while it is one of the most frequent autoimmune abnormalities accompanying Addison's disease (Kasperlik-Załuska et al., 1995) . Interestingly, ACTH deficiency appeared in a patient with a 18-year history of Addison's disease and coexisting primary hypothyroidism. Combined primary and secondary adrenal insufficiency was described by Vandeput et al. (1982) and Pholsena et al. (1994) . In this last case panhypopituitarism and primary adrenal failure were detected simultaneously. We did not find any report on thrombocytopaenia with a fatal outcome associated with secondary adrenal insufficiency.
The CT or MR images of empty sella or partially empty sella may be seen in the late period of the autoimmune pituitary disease. Komatsu et al. (1988) found antibodies against corticotroph cells in 75% of 32 cases of the primary empty sella syndrome and antibodies against prolactin in 47%. These results suggest autoimmunity as a cause of pituitary destruction resulting in the empty sella syndrome. Selective autoantibodies against corticotrophin-producing cells provoke the isolated ACTH deficiency. In our group of patients isolated secondary adrenal insufficiency was the most frequent clinical entity of pituitary origin. In only two patients (15, 23) with primary hypothyroidism were low TSH levels found and in one postmenopausal patient (23) low gonadotrophin levels were detected, suggesting a simultaneous autoimmune destruction of TSH and gonadotrophin-secreting cells, respectively. Assuming that lymphocytic hypophysitis resulted in partial pituitary destruction in our series of patients, we must ask why the corticotrophs have become the target cells of the autoimmune process in most cases. It may be speculated that corticotroph cells, as the most functionally active ones during a severe stress of lymphocytic infiltration, also became the most vulnerable.
In conclusion, the co-existence of rare disorders such as isolated ACTH deficiency, pernicious anaemia, thyroid autoimmunity, IDDM, premature ovarian failure, vitiligo, thrombocytopaenia and Addison's disease suggest a possibility of a common autoimmune mechanism. Our data and those found on reviewing the literature suggest that autoimmunity may be one of the most frequent causes of secondary adrenal insufficiency.
